the Beckman Coulter Foundation, during the third quarter 2007. The
purpose of the non-profit Beckman Coulter Foundation is to benefit
research and educational purposes. The donation is classified under
other non-operating expense.
f) Supply Chain Relocation - In January 2007, as part of our previously
announced strategic supply chain management initiative, we announced
the closure and relocation of certain manufacturing and distribution
sites, mainly in the United States. In connection with these
closures and relocations, we recorded charges related to severance
and other costs of $4.2 million in the fourth quarter of 2007.
Total supply chain relocation charges for full year 2007 were $16.9
million. During the second quarter of 2007 we recorded related
asset impairment charges of $0.8 million.
g) Agencourt Personal Genomics ("APG") - In July 2006, we sold our non-
controlling interest in APG, a developer of next-generation genetic
technologies. We received approximately $50 million in cash and
recognized a gain from the sale. This gain and our share of APG's
operating results of $28.7 million, net of taxes, are included in
discontinued operations. Also, in connection with the sale an
additional $6.0 million ($1.6 million, net of taxes) was held in
escrow. In July 2007, pursuant to the terms of the sale agreement,
we received $2.6 million, our proportional share of $6.0 million
held in escrow. The additional gain on sale of $2.6 million was
recorded in discontinued operations for the third quarter 2007.
h) Restructuring Related Charges - In July 2005, we announced a
strategic reorganization of our business to comb
|SOURCE Beckman Coulter, Inc.|
Copyright©2008 PR Newswire.
All rights reserved